[
  {
    "publication_date": "2026-07-08",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Yasir Al-Wakeel",
    "person_in_leading_position": "Yasir Al-Wakeel",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Depåbevis",
    "instrument_name": "Vicore pharma holding adr",
    "isin": "US92581R1041",
    "transaction_date": "2026-07-08",
    "volume": 363.0,
    "volume_raw": "363,0",
    "volume_unit": "Antal",
    "price": 13.7899,
    "price_raw": "13,7899",
    "currency": "USD",
    "trading_venue": "NASDAQ CAPITAL MARKET",
    "transaction_value": 5005.7337,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-07-07",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Hans Lennart Jeppsson",
    "person_in_leading_position": "Hans Lennart Jeppsson",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Depåbevis",
    "instrument_name": "Vicore Pharma Holding ADR",
    "isin": "US92581R1041",
    "transaction_date": "2026-07-06",
    "volume": 3.0,
    "volume_raw": "3,0",
    "volume_unit": "Antal",
    "price": 13.9,
    "price_raw": "13,9",
    "currency": "USD",
    "trading_venue": "NASDAQ CAPITAL MARKET",
    "transaction_value": 41.7,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-07-06",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Ahmed Mousa",
    "person_in_leading_position": "Ahmed Mousa",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Depåbevis",
    "instrument_name": "Vicore Pharma Holding ADR",
    "isin": "US92581R1041",
    "transaction_date": "2026-07-06",
    "volume": 670.0,
    "volume_raw": "670,0",
    "volume_unit": "Antal",
    "price": 14.9,
    "price_raw": "14,90",
    "currency": "USD",
    "trading_venue": "NASDAQ CAPITAL MARKET",
    "transaction_value": 9983.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-15",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "peter guenter",
    "person_in_leading_position": "peter guenter",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2026-06-12",
    "volume": 160220.0,
    "volume_raw": "160220,0",
    "volume_unit": "Antal",
    "price": 10.560269,
    "price_raw": "10,560269",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 1691966.29918,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-07-01",
    "issuer": "VICORE PHARMA HOLDING AB (publ)",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Elisabeth Björk",
    "person_in_leading_position": "Elisabeth Björk",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "Ja",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2025-07-01",
    "volume": 30652.0,
    "volume_raw": "30652,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-15",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Ahmed Mousa",
    "person_in_leading_position": "Ahmed Mousa",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2025-05-13",
    "volume": 11034.0,
    "volume_raw": "11034,0",
    "volume_unit": "Antal",
    "price": 8.24,
    "price_raw": "8,24",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 90920.16,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-15",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Ahmed Mousa",
    "person_in_leading_position": "Ahmed Mousa",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2025-05-13",
    "volume": 757.0,
    "volume_raw": "757,0",
    "volume_unit": "Antal",
    "price": 8.23,
    "price_raw": "8,23",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 6230.110000000001,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-12",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Johannes Schikan",
    "person_in_leading_position": "Johannes Schikan",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2025-05-08",
    "volume": 10000.0,
    "volume_raw": "10000,0",
    "volume_unit": "Antal",
    "price": 7.9,
    "price_raw": "7,90",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 79000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-12",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Johannes Schikan",
    "person_in_leading_position": "Johannes Schikan",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2025-05-08",
    "volume": 10000.0,
    "volume_raw": "10000,0",
    "volume_unit": "Antal",
    "price": 7.8,
    "price_raw": "7,80",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 78000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-12",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Johannes Schikan",
    "person_in_leading_position": "Johannes Schikan",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2025-05-08",
    "volume": 10000.0,
    "volume_raw": "10000,0",
    "volume_unit": "Antal",
    "price": 7.8,
    "price_raw": "7,80",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 78000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-05-12",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Johannes Schikan",
    "person_in_leading_position": "Johannes Schikan",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2025-05-08",
    "volume": 10000.0,
    "volume_raw": "10000,0",
    "volume_unit": "Antal",
    "price": 7.7,
    "price_raw": "7,70",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 77000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-10-09",
    "issuer": "Vicore Pharma Holding AB (publ)",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Hans Lennart Jeppsson",
    "person_in_leading_position": "Hans Lennart Jeppsson",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Vicore Pharma Holding AB BTA",
    "isin": "SE0022760468",
    "transaction_date": "2024-10-08",
    "volume": 444.0,
    "volume_raw": "444,0",
    "volume_unit": "Antal",
    "price": 7.0,
    "price_raw": "7,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 3108.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-10-08",
    "issuer": "Vicore Pharma Holding AB (publ)",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Johannes Schikan",
    "person_in_leading_position": "Johannes Schikan",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Vicore Pharma Holding AB BTA",
    "isin": "SE0022760468",
    "transaction_date": "2024-10-08",
    "volume": 4000.0,
    "volume_raw": "4000,0",
    "volume_unit": "Antal",
    "price": 7.0,
    "price_raw": "7,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 28000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-10-08",
    "issuer": "Vicore Pharma Holding AB (publ)",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Hans Lennart Jeppsson",
    "person_in_leading_position": "Hans Lennart Jeppsson",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Vicore Pharma Holding AB BTA",
    "isin": "SE0022760468",
    "transaction_date": "2024-10-04",
    "volume": 5000.0,
    "volume_raw": "5000,0",
    "volume_unit": "Antal",
    "price": 7.0,
    "price_raw": "7,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 35000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-10-07",
    "issuer": "Vicore Pharma Holding AB (publ)",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Jacob Uno Stanley Gunterberg",
    "person_in_leading_position": "Jacob Uno Stanley Gunterberg",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Vicore Pharma Holding AB BTA",
    "isin": "SE0022760468",
    "transaction_date": "2024-10-04",
    "volume": 6400.0,
    "volume_raw": "6400,0",
    "volume_unit": "Antal",
    "price": 7.0,
    "price_raw": "7,00",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 44800.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-09-24",
    "issuer": "Vicore Pharma Holding AB.",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Ann Barbier",
    "person_in_leading_position": "Ann Barbier",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB.",
    "isin": "SE0007577895",
    "transaction_date": "2024-09-23",
    "volume": 42500.0,
    "volume_raw": "42500,0",
    "volume_unit": "Antal",
    "price": 7.03,
    "price_raw": "7,03",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 298775.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-09-11",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Ahmed Mousa",
    "person_in_leading_position": "Ahmed Mousa",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2024-09-11",
    "volume": 32000.0,
    "volume_raw": "32000,0",
    "volume_unit": "Antal",
    "price": 7.7553,
    "price_raw": "7,7553",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 248169.6,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-09-11",
    "issuer": "Vicore Pharma Holding AB",
    "lei": "549300KTNBPTZLF01130",
    "reporting_person": "Ahmed Mousa",
    "person_in_leading_position": "Ahmed Mousa",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Vicore Pharma Holding AB",
    "isin": "SE0007577895",
    "transaction_date": "2024-09-10",
    "volume": 95000.0,
    "volume_raw": "95000,0",
    "volume_unit": "Antal",
    "price": 7.9184,
    "price_raw": "7,9184",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 752248.0,
    "status": "Aktuell",
    "is_current_report": true
  }
]